ESKENAZI HEALTH
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.1M
- Transactions
- 84
- Companies
- 25
- Average per transaction
- $25,475
Who reported the payments
| Gilead | $1,252,820 |
| Eli Lilly | $833,147 |
| Stryker | $23,916 |
| Johnson & Johnson | $9,444 |
| Biofire Diagnostics, LLC | $6,473 |
| Edwards Lifesciences | $3,686 |
| Werfen USA LLC | $2,356 |
| Chiesi USA, Inc. | $1,460 |
| Olympus America Inc. | $1,349 |
| Genentech USA, Inc. | $900 |
| Johnson & Johnson Surgical Vision, Inc. | $645 |
| Fisher Scientific Company L.L.C. | $562 |
| Linvatec Corporation | $540 |
| AstraZeneca | $535 |
| Avanir Pharmaceuticals, Inc. | $400 |
| Cochlear Americas | $388 |
| Advanced Respiratory, Inc | $250 |
| Covidien LP | $250 |
| Zimmer Biomet | $235 |
| Aesculap, Inc. | $171 |
| Siemens Medical Solutions USA, Inc. | $127 |
| Monaghan Medical Corporation | $125 |
| BD | $100 |
| Baxter Healthcare | $27 |
| GE HealthCare | $26 |